BD falls on disappointing Q1; Allergan to create jobs in Ireland;

> With healthcare utilization still down, and the positive sales impact of H1N1 flu now in the past, medical devicemaker Becton Dickinson saw sales slip in the first quarter. Shares fell 5.3 percent in midday trading. Report

> The maker of Botox is to create 20 new jobs at its facility in Westport, Co Mayo. U.S.-based pharmaceutical company, Allegran, is making a $10 million investment in new medical technology at its Mayo site. The new investment will see Allergan manufacturing a medical device used in a number of surgical procedures in Westport. Story

> Medtronic subsidiary Physio-Control will partner with a California company to distribute its cardiac medical device in Europe and develop new uses to ready it for launch in the U.S. Item

> Concentric Medical announces first patients enrolled in TREVO 2 clinical trial. Concentric release

> Global Capital Management, the alternative asset management arm of Global Investment House (Global), announced today that the Global Buyout Fund has successfully acquired 80 percent of Bıçakcılar Tıbbi Cihazlar A.Ş. and its group of companies (Bıçakcılar), the leading manufacturer of medical equipment and disposables, and distributor of cardiovascular and neurosurgery products in Turkey. Article

> Natus Medical has appointed John Buhler as president and COO. Natus release

> A federal judge in Delaware denies an Edwards Lifesciences move to bar U.S. manufacturing and sale of its CoreValve aortic valve replacement, despite losing a $74 million judgment in the case. News

And Finally... A prototype wireless electroencephalogram (EEG) headset debuts this week at the Medical Device and Manufacturing conference and exhibition in Anaheim, CA, and European developers IMEC and Holst Centre say it could lead to not just neuro-feedback but improved safety (no more sleeping behind the wheel) and entertainment (real-time video game adjustments based on the user's mood). News

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.